| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2009;120:1847-1849.)
© 2009 American Heart Association, Inc.
Editorial |
From the CNR Institute of Clinical Physiology, Pisa, Italy, and G. Monasterio Foundation, Massa, Italy.
Correspondence to Dr Maria Grazia Andreassi, CNR Institute of Clinical Physiology, G. Monasterio Foundation, Via Aurelia Sud-Montepepe, 54100 Massa, Italy. E-mail andreas@ifc.cnr.it
Key Words: Editorials heart defects, congenital radiation pediatrics
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
| Introduction |
|---|
Article see p 1903
Indeed, grown-up patients with surgically repaired CHD are a large and growing population, estimated to be 1 million in United States in the year 2000 compared with an estimated 300 000 in 1980, and 1.4 million cases are anticipated in 2020.2 Numbers are likely to be similar in the European Union, although no hard figures are available.3
One worrisome social and medical problem in the management of patients with CHD is certainly the long-term effects of intensive medical exposure to ionizing radiation received during childhood, especially for interventional catheterization procedures.4–7 Pediatric cardiac catheterizations are undoubtedly an essential diagnostic and therapeutic tool for the diagnosis and the treatment of CHD; however, they also deliver one of the highest radiation doses to patients.4–7
Ionizing radiation exposure is a definite risk factor for cancer development. Children are especially vulnerable to the oncogenic effects of radiation. Tissues and organs that are growing and developing are more sensitive to radiation effects than those that are fully mature.
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2009 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |